Choosing First-Line Treatment of Metastatic Colorectal Cancer Based on Biomarker Ras Status- A Budget Impact Analysis From Brazilian Health Insurance System Perspective
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.2127
https://www.valueinhealthjournal.com/article/S1098-3015(16)33493-3/fulltext
Section Title :
Disease-Specific Studies
Section Order :
2017
First Page :
A718
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33493-3&doi=10.1016/j.jval.2016.09.2127